Masako Sakuragi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Patients Undergoing

Glycemic Control

Top Venues

Journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata
Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus. Journal of breast cancer 27 (2) (2024)
Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata
Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus. Journal of breast cancer (2024)
Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata
Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus. Journal of breast cancer 27 (2) (2024)
Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata
Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus. Journal of breast cancer 27 (2) (2024)
Satomi Shiba, Michiko Harao, Akira Saito, Masako Sakuragi, Joji Kitayama, Naohiro Sata
Metformin Alters Tumor Immune Microenvironment, Improving the Outcomes of Breast Cancer Patients With Type 2 Diabetes Mellitus. Journal of breast cancer 27 (2) (2024)